The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice (original) (raw)

Abstract

Background: Obesity and insulin resistance are two major risk factors underlying the metabolic syndrome. The development of these metabolic disorders is frequently studied, but mainly in liver, skeletal muscle, and adipose tissue. To gain more insight in the role of the small intestine in development of obesity and insulin resistance, dietary fat-induced differential gene expression was determined along the longitudinal axis of small intestines of C57BL/6J mice.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (51)

  1. Moller DE, Kaufman KD: METABOLIC SYNDROME: A Clinical and Molecular Perspective. Annual Review of Medicine 2005, 56(1):45-62.
  2. Laaksonen DE, Niskanen L, Lakka HM, Lakka TA, Uusitupa M: Epide- miology and treatment of the metabolic syndrome. Ann Med 2004, 36(5):332-346.
  3. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 2000, 106(4):473-481.
  4. Winzell MS, Ahren B: The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tol- erance and type 2 diabetes. Diabetes 2004, 53 Suppl 3:S215-9.
  5. Kondo H, Minegishi Y, Komine Y, Mori T, Matsumoto I, Abe K, Tokimitsu I, Hase T, Murase T: Differential regulation of intesti- nal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab 2006, 291(5):E1092-1099.
  6. Backhed F, Manchester JK, Semenkovich CF, Gordon JI: From the Cover: Mechanisms underlying the resistance to diet- induced obesity in germ-free mice. PNAS 2007, 104(3):979-984.
  7. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM: Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC- 1[beta] Coactivation of SREBP. Cell 2005, 120(2):261.
  8. Roche HM, Phillips C, Gibney MJ: The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 2005, 64(3):371-377.
  9. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR: A High-Fat Diet Coordinately Downregulates Genes Required for Mitochondrial Oxidative Phosphorylation in Skeletal Muscle. Diabetes 2005, 54(7):1926-1933.
  10. Kreeft AJ, Moen CJA, Porter G, Kasanmoentalib S, Sverdlov R, van Gorp PJ, Havekes LM, Frants RR, Hofker MH: Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regula- tion of lipid and inflammatory genes. Atherosclerosis 2005, 182(2):249.
  11. Campion J, Milagro FI, Fernandez D, Martinez JA: Diferential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity. J Physiol Bio- chem 2006, 62(2):71-80.
  12. Cummings DE, Overduin J: Gastrointestinal regulation of food intake. J Clin Invest 2007, 117(1):13-23.
  13. Drucker DJ: The role of gut hormones in glucose homeostasis. J Clin Invest 2007, 117(1):24-32.
  14. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027.
  15. Schurch AF, Lloyd LE, Crampton EW: The use of chromic oxide as an index for determining the digestibility of a diet. J Nutr 1950, 41(4):629-636.
  16. Lee H, Braynen W, Keshav K, Pavlidis P: ErmineJ: Tool for func- tional analysis of gene expression data sets. BMC Bioinformatics 2005, 6(1):269.
  17. Wang X, Seed B: A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003, 31(24):e154.
  18. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers . In Bioinformatics Methods and Protocols: Methods in Molecular Biology Edited by: Krawetz S, Misener S. Totowa, NJ, Humana Press; 2000:365-386.
  19. Kota RS, Rutledge JC, Gohil K, Kumar A, Enelow RI, Ramana CV: Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-[gamma]. Biochemical and Biophysical Research Communications 2006, 342(4):1137.
  20. Rhee SJ, Walker WA, Cherayil BJ: Developmentally Regulated Intestinal Expression of IFN-{gamma} and Its Target Genes and the Age-Specific Response to Enteric Salmonella Infec- tion. J Immunol 2005, 175(2):1127-1136.
  21. Desvergne B, Michalik L, Wahli W: Transcriptional Regulation of Metabolism. Physiol Rev 2006, 86(2):465-514.
  22. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science 1999, 284(5418):1362-1365.
  23. Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M: Genome-wide analysis of PPAR{alpha} activa- tion in murine small intestine. Physiol Genomics 2007.
  24. Jansen GR, Hutchon CF, Zanetti ME: Studies on lipogenesis in vivo. Effect of dietary fat or starvation on conversion of [14]glucose into fat ad turnover of newly synthsized fat. Bio- chem J 1966, 99(2):323-332.
  25. Acheson KJ, Schutz Y, Bessard T, Ravussin E, Jequier E, Flatt JP: Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. Am J Physiol Endocrinol Metab 1984, 246(1):E62-70.
  26. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
  27. Tobin JF, Freedman LP: Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy. Trends in Endocrinology & Metabolism 2006, 17(7):284-290.
  28. Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B: PPAR-{alpha}-Null Mice Are Protected From High-Fat Diet-Induced Insulin Resistance. Diabetes 2001, 50(12):2809-2814.
  29. Patsouris D, Reddy JK, Muller M, Kersten S: Peroxisome Prolifer- ator-Activated Receptor {alpha} Mediates the Effects of High-Fat Diet on Hepatic Gene Expression. Endocrinology 2006, 147(3):1508-1516.
  30. Vega RB, Huss JM, Kelly DP: The Coactivator PGC-1 Cooper- ates with Peroxisome Proliferator-Activated Receptor alpha in Transcriptional Control of Nuclear Genes Encoding Mito- chondrial Fatty Acid Oxidation Enzymes. Mol Cell Biol 2000, 20(5):1868-1876.
  31. Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, Dohm GL, Yan Z, Newgard CB, Muoio DM: Peroxisome Proliferator-activated Receptor-{gamma} Co-activator 1{alpha}-mediated Meta- bolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Ineffi- ciency. J Biol Chem 2005, 280(39):33588-33598.
  32. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM: PPAR{delta} reg- ulates glucose metabolism and insulin sensitivity. PNAS 2006, 103(9):3444-3449.
  33. Rahman SM, Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Ntambi JM: Stearoyl-CoA desaturase 1 deficiency elevates insulin-signal- ing components and down-regulates protein-tyrosine phos- phatase 1B in muscle. PNAS 2003, 100(19):11110-11115.
  34. Gutierrez-Juarez R, Pocai A, Mulas C, Ono H, Bhanot S, Monia BP, Rossetti L: Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 2006, 116(6):1686-1695.
  35. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M: Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulo- sclerosis via a Sterol Regulatory Element-binding Protein- 1c-dependent Pathway. J Biol Chem 2005, 280(37):32317-32325.
  36. Wang L, Liu J, Saha P, Huang J, Chan L, Spiegelman B, Moore DD: The orphan nuclear receptor SHP regulates PGC-1[alpha] expression and energy production in brown adipocytes. Cell Metabolism 2005, 2(4):227.
  37. Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ, Tack CJ, van Krieken H, Kim SH, Stalenhoef AF, van de Loo FA, Ver- schueren I, Pulawa L, Akira S, Eckel RH, Dinarello CA, van den Berg W, van der Meer JW: Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12(6):650-656.
  38. Zorrilla EP, Sanchez-Alavez M, Sugama S, Brennan M, Fernandez R, Bartfai T, Conti B: Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A 2007, 104(26):11097-11102.
  39. Church TS, Willis MS, Priest EL, Lamonte MJ, Earnest CP, Wilkinson WJ, Wilson DA, Giroir BP: Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 2005, 29(6):675-681.
  40. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rath- mann W, Holle R, Thorand B, Wichmann HE: Association of Sys- temic Concentrations of Macrophage Migration Inhibitory Factor With Impaired Glucose Tolerance and Type 2 Diabe- tes: Results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 2006, 29(2):368-371.
  41. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, Stewart TA: Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin- Deficient Diabetes. Endocrinology 2004, 145(6):2594-2603.
  42. Silha JV, Gui Y, Murphy LJ: Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am J Physiol Endocrinol Metab 2002, 283(5):E937-945.
  43. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S: The fasting-induced adipose factor/angiopoietin- like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006, 281(2):934-944.
  44. Desai U, Lee EC, Chung K, Gao C, Gay J, Key B, Hansen G, Mach- ajewski D, Platt KA, Sands AT, Schneider M, Van Sligtenhorst I, Suwanichkul A, Vogel P, Wilganowski N, Wingert J, Zambrowicz BP, Landes G, Powell DR: Lipid-lowering effects of anti-angiopoie- tin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci U S A 2007, 104(28):11766-11771.
  45. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR: [beta]-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007, 13(3):340-347.
  46. Duran-Sandoval D, Cariou B, Fruchart JC, Staels B: Potential regu- latory role of the farnesoid X receptor in the metabolic syn- drome. Biochimie 2005, 87(1):93.
  47. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Gref- horst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B: The Farnesoid X Receptor Modulates Adi- posity and Peripheral Insulin Sensitivity in Mice. J Biol Chem 2006, 281(16):11039-11049.
  48. Kalaany NY, Gauthier KC, Zavacki AM, Mammen PPA, Kitazume T, Peterson JA, Horton JD, Garry DJ, Bianco AC, Mangelsdorf DJ: LXRs regulate the balance between fat storage and oxidation. Cell Metabolism 2005, 1(4):231.
  49. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Kad- owaki T: PPAR gamma mediates high-fat diet-induced adi- pocyte hypertrophy and insulin resistance. Mol Cell 1999, 4(4):597-609.
  50. Miles PDG, Barak Y, He W, Evans RM, Olefsky JM: Improved insu- lin-sensitivity in mice heterozygous for PPAR-{gamma} defi- ciency. J Clin Invest 2000, 105(3):287-292.
  51. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenk- ovich CF, Kelly DP: PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnor- mal weight control and hepatic steatosis. PLoS Biol 2005, 3(4):e101.